Some studies suggest that synovial sarcoma patients with the fusion gene, SS18-SSX2, have better prognoses than those with the fusion gene, SS18-SSX1 [77,78], but the difference in prognoses was not reproduced in other studies [79,80]. Here, SS18 is linked to synovial sarcoma.